Skip to main content
Stem Cell Research & Therapy logoLink to Stem Cell Research & Therapy
. 2024 Feb 27;15:52. doi: 10.1186/s13287-024-03668-6

Retraction Note: Mesenchymal stem cells ameliorate renal fibrosis by galectin-3/Akt/GSK3β/Snail signaling pathway in adenine-induced nephropathy rat

Huajun Tang 1, Peiyue Zhang 1, Lianlin Zeng 1, Yu Zhao 1, Libo Xie 2,, Bo Chen 1,
PMCID: PMC10897979  PMID: 38409032

Retraction Note: Stem Cell Research & Therapy (2021) 12:409

10.1186/s13287-021-02429-z

RETRACTION NOTE.

The Editors in Chief have retracted this article after concerns were raised about the data reported. Specifically:

  • In Fig. 7a, there is evidence of a potential splice between lanes 2 and 3 of GAPDH blot.

  • The GAPDH blot of Fig. 11a appears to duplicate the GAPDH blot of Fig. 11c. In Fig. 11c, there is also evidence of a potential splice between lanes 1 and 2 of Galectin 3 blot.

  • In Fig. 15, several panels appear to partially or wholly duplicate one another: the TGF-β1 + DMEM/F12-treated subgroup of control and the TGF-β1 + MSCs-CM-treated subgroup of Gal-3 OE (both α-SMA); the MSCs-CM-treated subgroup of control (E-Cadherin) and the normal subgroup of Gal-3OE (α-SMA); and the TGF-β1 + DMEM/F12-treated subgroup of control (E-Cadherin) and the normal subgroup of control (α-SMA).

The Editors in Chief therefore no longer have confidence in the reliability of the data presented. Bo Chen has stated on behalf of all authors that they agree with the retraction.

Footnotes

The online version of the original article can be found at 10.1186/s13287-021-02429-z.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Stem Cell Research & Therapy are provided here courtesy of BMC

RESOURCES